Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One, GenomiCare Partner on Interpreting NGS Tests in China

NEW YORK (GenomeWeb) – N-of-One today announced that it has signed an agreement to provide clinical interpretations for GenomiCare's next-generation sequencing-based oncology panels in China.

N-of-One provides therapeutic strategies relevant to specific cancer cases based on genomic data. Shanghai-based GenomiCare uses NGS to identify mutations and copy number variations across a tumor's exome.

"[T]he combination of this rich clinical knowledge, along with GenomiCare's multiple avenues to connect patients with China-focused treatment solutions, will significantly benefit Chinese cancer patients," GenomiCare President Qiang Xu said in a statement.

Financial and other details of the agreement were not disclosed.

Last month, N-of-One signed an agreement to provide clinical interpretation for CompanionDx. In May, the firm signed a copy number variation interpretation deal with Affymetrix.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.